Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma
Clinical trial NCT03168594 · TERMINATED
Trial details
- NCT number
- NCT03168594
- Sponsor
- Peking University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-29
- Primary completion
- 2019-02-20
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.